Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Proteins | 78 | 2024 | 5802 | 7.030 |
Why?
|
Oncogene Proteins | 40 | 2018 | 718 | 6.170 |
Why?
|
Oncogene Proteins, Fusion | 39 | 2023 | 1614 | 4.320 |
Why?
|
Carcinoma | 36 | 2023 | 2340 | 4.150 |
Why?
|
Carcinoma, Squamous Cell | 33 | 2023 | 4069 | 3.180 |
Why?
|
Neoplasm Proteins | 53 | 2024 | 3609 | 2.670 |
Why?
|
Transcription Factors | 37 | 2023 | 12166 | 2.160 |
Why?
|
Cell Cycle Proteins | 29 | 2023 | 3457 | 2.100 |
Why?
|
Gene Rearrangement | 24 | 2018 | 1139 | 1.510 |
Why?
|
E1A-Associated p300 Protein | 3 | 2020 | 125 | 1.300 |
Why?
|
Translocation, Genetic | 16 | 2018 | 1395 | 1.170 |
Why?
|
Mediastinal Neoplasms | 7 | 2016 | 403 | 1.170 |
Why?
|
In Situ Hybridization, Fluorescence | 23 | 2022 | 2524 | 1.090 |
Why?
|
Gene Fusion | 4 | 2022 | 356 | 0.890 |
Why?
|
Chromosomes, Human, Pair 15 | 9 | 2017 | 361 | 0.780 |
Why?
|
p300-CBP Transcription Factors | 2 | 2021 | 150 | 0.710 |
Why?
|
Chromosomes, Human, Pair 19 | 6 | 2017 | 350 | 0.700 |
Why?
|
Germ Cells | 2 | 2022 | 643 | 0.620 |
Why?
|
Antineoplastic Agents | 7 | 2023 | 13696 | 0.600 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 775 | 0.590 |
Why?
|
Chloride Channels | 1 | 2018 | 222 | 0.560 |
Why?
|
Chromatin | 7 | 2023 | 2967 | 0.520 |
Why?
|
Lung Neoplasms | 13 | 2023 | 13576 | 0.510 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2016 | 325 | 0.500 |
Why?
|
Cell Line, Tumor | 15 | 2023 | 17132 | 0.480 |
Why?
|
Benzimidazoles | 1 | 2020 | 864 | 0.480 |
Why?
|
Acetanilides | 1 | 2016 | 169 | 0.470 |
Why?
|
Pyridones | 1 | 2020 | 818 | 0.470 |
Why?
|
Head and Neck Neoplasms | 4 | 2022 | 2923 | 0.470 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3666 | 0.460 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2021 | 997 | 0.440 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2830 | 0.440 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2016 | 295 | 0.430 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2020 | 8628 | 0.420 |
Why?
|
Tumor Suppressor Proteins | 3 | 2021 | 2811 | 0.410 |
Why?
|
Turbinates | 1 | 2013 | 66 | 0.410 |
Why?
|
Laryngeal Neoplasms | 6 | 2017 | 515 | 0.390 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2011 | 290 | 0.390 |
Why?
|
Immunohistochemistry | 18 | 2022 | 11117 | 0.390 |
Why?
|
Small Molecule Libraries | 2 | 2020 | 743 | 0.390 |
Why?
|
Sarcoma | 2 | 2018 | 1806 | 0.350 |
Why?
|
Maxillary Sinus Neoplasms | 3 | 2018 | 38 | 0.350 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2014 | 697 | 0.330 |
Why?
|
Cell Differentiation | 10 | 2018 | 11659 | 0.330 |
Why?
|
Humans | 107 | 2024 | 768298 | 0.320 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2009 | 46 | 0.320 |
Why?
|
Nose Neoplasms | 4 | 2012 | 250 | 0.310 |
Why?
|
Digestive System Neoplasms | 1 | 2009 | 83 | 0.310 |
Why?
|
Testicular Neoplasms | 2 | 2021 | 805 | 0.310 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2008 | 26 | 0.310 |
Why?
|
Thyroid Neoplasms | 4 | 2018 | 2360 | 0.310 |
Why?
|
Neoplasms | 9 | 2021 | 22389 | 0.300 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2023 | 11854 | 0.300 |
Why?
|
Sarcoma, Small Cell | 1 | 2007 | 17 | 0.300 |
Why?
|
SOXB1 Transcription Factors | 3 | 2021 | 285 | 0.290 |
Why?
|
Adolescent | 31 | 2024 | 89182 | 0.280 |
Why?
|
Fatal Outcome | 7 | 2017 | 1837 | 0.270 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3236 | 0.270 |
Why?
|
Cytogenetic Analysis | 2 | 2012 | 270 | 0.260 |
Why?
|
Repressor Proteins | 1 | 2017 | 2986 | 0.260 |
Why?
|
Parotid Neoplasms | 3 | 2018 | 158 | 0.260 |
Why?
|
Cell Proliferation | 5 | 2020 | 10464 | 0.250 |
Why?
|
Rhinitis | 1 | 2013 | 751 | 0.240 |
Why?
|
Young Adult | 21 | 2024 | 60048 | 0.240 |
Why?
|
Ifosfamide | 2 | 2023 | 234 | 0.240 |
Why?
|
Thymus Neoplasms | 2 | 2021 | 277 | 0.240 |
Why?
|
Female | 60 | 2024 | 397050 | 0.240 |
Why?
|
PPAR gamma | 1 | 2008 | 487 | 0.240 |
Why?
|
RNA-Binding Proteins | 5 | 2016 | 1883 | 0.230 |
Why?
|
Adult | 45 | 2024 | 223622 | 0.220 |
Why?
|
Sinusitis | 1 | 2013 | 995 | 0.220 |
Why?
|
Cell Nucleus | 5 | 2018 | 2887 | 0.220 |
Why?
|
Histones | 3 | 2023 | 2593 | 0.220 |
Why?
|
Middle Aged | 38 | 2024 | 223463 | 0.210 |
Why?
|
Thyroid Gland | 2 | 2022 | 1172 | 0.210 |
Why?
|
Endoscopy | 1 | 2013 | 1856 | 0.210 |
Why?
|
Male | 57 | 2024 | 364870 | 0.210 |
Why?
|
Aged | 29 | 2024 | 171544 | 0.210 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 2056 | 0.200 |
Why?
|
Tumor Cells, Cultured | 4 | 2020 | 6132 | 0.200 |
Why?
|
Child | 22 | 2024 | 80894 | 0.200 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9618 | 0.200 |
Why?
|
N-Methylaspartate | 1 | 2022 | 231 | 0.200 |
Why?
|
Streptococcus pyogenes | 1 | 2024 | 293 | 0.200 |
Why?
|
Epithelial Cells | 2 | 2017 | 3692 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2023 | 2846 | 0.180 |
Why?
|
Azepines | 2 | 2020 | 329 | 0.180 |
Why?
|
Dendrites | 1 | 2022 | 472 | 0.170 |
Why?
|
Streptococcal Infections | 1 | 2024 | 619 | 0.170 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2565 | 0.170 |
Why?
|
Tracheal Neoplasms | 1 | 2020 | 124 | 0.170 |
Why?
|
Genes, Tumor Suppressor | 1 | 2023 | 1064 | 0.160 |
Why?
|
Sialoglycoproteins | 1 | 2020 | 320 | 0.160 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2016 | 243 | 0.160 |
Why?
|
RNA, Small Interfering | 3 | 2017 | 3436 | 0.160 |
Why?
|
Thoracic Neoplasms | 2 | 2013 | 269 | 0.160 |
Why?
|
Abnormalities, Severe Teratoid | 1 | 1998 | 5 | 0.160 |
Why?
|
Lipoma | 1 | 2000 | 296 | 0.150 |
Why?
|
Survival Rate | 3 | 2023 | 12870 | 0.150 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 861 | 0.150 |
Why?
|
Aged, 80 and over | 14 | 2024 | 59683 | 0.150 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 59 | 0.140 |
Why?
|
Diagnosis, Differential | 7 | 2022 | 13019 | 0.140 |
Why?
|
Mice | 7 | 2023 | 82004 | 0.140 |
Why?
|
Child, Preschool | 12 | 2024 | 42654 | 0.140 |
Why?
|
Lymphoproliferative Disorders | 1 | 2000 | 529 | 0.140 |
Why?
|
Pericardiocentesis | 1 | 2017 | 78 | 0.140 |
Why?
|
Fetal Diseases | 3 | 1998 | 916 | 0.140 |
Why?
|
Fetal Heart | 1 | 1998 | 281 | 0.140 |
Why?
|
Phylogeny | 1 | 2024 | 2842 | 0.140 |
Why?
|
Sublingual Gland Neoplasms | 1 | 2015 | 2 | 0.130 |
Why?
|
Femoral Neck Fractures | 1 | 2017 | 143 | 0.130 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6670 | 0.130 |
Why?
|
Proteins | 2 | 2021 | 6006 | 0.130 |
Why?
|
Histone Chaperones | 1 | 2016 | 85 | 0.130 |
Why?
|
Cardiac Tamponade | 1 | 2017 | 175 | 0.130 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 186 | 0.130 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1839 | 0.130 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2016 | 375 | 0.120 |
Why?
|
Benzodiazepines | 1 | 2021 | 1139 | 0.120 |
Why?
|
Adenocarcinoma | 3 | 2021 | 6404 | 0.120 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6856 | 0.120 |
Why?
|
Acetylation | 3 | 2016 | 1053 | 0.120 |
Why?
|
Arcobacter | 1 | 2014 | 1 | 0.120 |
Why?
|
Mice, SCID | 1 | 2020 | 2632 | 0.120 |
Why?
|
Zinc Fingers | 1 | 2017 | 577 | 0.120 |
Why?
|
Animals | 10 | 2023 | 169322 | 0.120 |
Why?
|
Adamantinoma | 1 | 2014 | 9 | 0.120 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 335 | 0.110 |
Why?
|
Transfection | 2 | 2013 | 5758 | 0.110 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 562 | 0.110 |
Why?
|
Femoral Neoplasms | 1 | 2014 | 85 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2012 | 9261 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 974 | 0.110 |
Why?
|
Antigens, CD34 | 3 | 2011 | 656 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2014 | 17626 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 793 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1141 | 0.100 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2013 | 239 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 954 | 0.100 |
Why?
|
Cell Cycle | 1 | 2020 | 2934 | 0.100 |
Why?
|
Seminoma | 1 | 2013 | 136 | 0.100 |
Why?
|
Neck | 1 | 2016 | 736 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3616 | 0.100 |
Why?
|
Biopsy | 4 | 2018 | 6808 | 0.090 |
Why?
|
Skin Neoplasms | 3 | 2019 | 5857 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15455 | 0.090 |
Why?
|
HEK293 Cells | 2 | 2017 | 4286 | 0.090 |
Why?
|
Azirines | 1 | 2010 | 30 | 0.090 |
Why?
|
Anticonvulsants | 3 | 2018 | 1923 | 0.090 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2012 | 93 | 0.090 |
Why?
|
Nasal Cavity | 2 | 2009 | 311 | 0.090 |
Why?
|
14-3-3 Proteins | 1 | 2012 | 222 | 0.090 |
Why?
|
Epilepsy | 2 | 2018 | 3326 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1111 | 0.090 |
Why?
|
Dihydropyridines | 1 | 2010 | 67 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 3779 | 0.090 |
Why?
|
Paired Box Transcription Factors | 1 | 2011 | 206 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1428 | 0.090 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2010 | 10 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 20766 | 0.090 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 982 | 0.090 |
Why?
|
Diagnostic Errors | 2 | 2016 | 1280 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2000 | 5898 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2021 | 65365 | 0.080 |
Why?
|
Biopsy, Fine-Needle | 2 | 2021 | 1131 | 0.080 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 8562 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4774 | 0.080 |
Why?
|
Placenta | 1 | 1998 | 1722 | 0.080 |
Why?
|
Infant | 5 | 2024 | 36512 | 0.080 |
Why?
|
Thyroid Nodule | 1 | 2016 | 766 | 0.080 |
Why?
|
Prognosis | 8 | 2022 | 30020 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2236 | 0.080 |
Why?
|
Preoperative Care | 1 | 2017 | 2257 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2015 | 1368 | 0.080 |
Why?
|
Antibody Specificity | 2 | 2009 | 1065 | 0.080 |
Why?
|
Phenotype | 3 | 2022 | 16716 | 0.080 |
Why?
|
RNA Interference | 1 | 2017 | 2836 | 0.080 |
Why?
|
Karyotyping | 2 | 2008 | 1173 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 5792 | 0.080 |
Why?
|
Infant, Newborn | 5 | 2024 | 26410 | 0.080 |
Why?
|
Hydroxamic Acids | 1 | 2011 | 482 | 0.070 |
Why?
|
Tibia | 1 | 2014 | 1075 | 0.070 |
Why?
|
Lymphatic Metastasis | 4 | 2018 | 2924 | 0.070 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2012 | 489 | 0.070 |
Why?
|
Mice, Nude | 2 | 2011 | 3630 | 0.070 |
Why?
|
Orbital Neoplasms | 1 | 2009 | 223 | 0.070 |
Why?
|
Anesthetics, Local | 1 | 2014 | 1003 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2020 | 5151 | 0.070 |
Why?
|
Neoplasm Staging | 3 | 2016 | 11254 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3826 | 0.070 |
Why?
|
Submandibular Gland | 2 | 2021 | 85 | 0.070 |
Why?
|
Histone Deacetylases | 1 | 2011 | 717 | 0.070 |
Why?
|
Chromosome Aberrations | 2 | 2012 | 1780 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1608 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2022 | 18047 | 0.060 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 1166 | 0.060 |
Why?
|
DNA, Neoplasm | 3 | 2010 | 1748 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9433 | 0.060 |
Why?
|
Aneuploidy | 2 | 2013 | 572 | 0.060 |
Why?
|
Cytodiagnosis | 2 | 2016 | 452 | 0.060 |
Why?
|
Arizona | 1 | 2024 | 108 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2819 | 0.060 |
Why?
|
Models, Molecular | 2 | 2014 | 5408 | 0.060 |
Why?
|
Multigene Family | 1 | 2007 | 1082 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2011 | 984 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9506 | 0.060 |
Why?
|
Electroencephalography | 1 | 2018 | 6317 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 2058 | 0.050 |
Why?
|
Rabbits | 1 | 2009 | 4782 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2394 | 0.050 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 250 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4419 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2018 | 81768 | 0.050 |
Why?
|
Recombination, Genetic | 3 | 2018 | 1526 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4584 | 0.050 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3631 | 0.050 |
Why?
|
Remission Induction | 1 | 2007 | 2407 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6541 | 0.050 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2024 | 403 | 0.050 |
Why?
|
False Negative Reactions | 2 | 2020 | 575 | 0.050 |
Why?
|
HeLa Cells | 1 | 2007 | 3092 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2001 | 777 | 0.050 |
Why?
|
Keratins | 2 | 2013 | 502 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5707 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2014 | 13425 | 0.050 |
Why?
|
alpha-Fetoproteins | 2 | 1994 | 227 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3541 | 0.040 |
Why?
|
Seizures | 1 | 2013 | 3000 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 14736 | 0.040 |
Why?
|
Mediastinum | 1 | 2021 | 272 | 0.040 |
Why?
|
Pyramidal Cells | 1 | 2022 | 367 | 0.040 |
Why?
|
S100 Proteins | 1 | 2000 | 217 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2013 | 534 | 0.040 |
Why?
|
Health Facilities | 1 | 2024 | 577 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4301 | 0.040 |
Why?
|
Protein Binding | 4 | 2014 | 9346 | 0.040 |
Why?
|
Testis | 1 | 2003 | 783 | 0.040 |
Why?
|
Genome, Bacterial | 1 | 2024 | 796 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2013 | 36849 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2024 | 1150 | 0.040 |
Why?
|
Chorion | 1 | 1998 | 112 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2014 | 2177 | 0.040 |
Why?
|
Cyclin T | 1 | 2017 | 19 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2017 | 7599 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9380 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4908 | 0.040 |
Why?
|
Base Sequence | 2 | 2007 | 12421 | 0.040 |
Why?
|
Genes | 1 | 2001 | 1824 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 545 | 0.040 |
Why?
|
Immunoenzyme Techniques | 1 | 2000 | 1705 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2017 | 68 | 0.040 |
Why?
|
Sarcoma, Synovial | 1 | 2018 | 156 | 0.040 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 905 | 0.040 |
Why?
|
Amnion | 1 | 1998 | 202 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4120 | 0.030 |
Why?
|
Oncogenes | 1 | 2003 | 1234 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2001 | 1704 | 0.030 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9197 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 1998 | 472 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2008 | 1640 | 0.030 |
Why?
|
Fetal Death | 1 | 1998 | 438 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2001 | 1093 | 0.030 |
Why?
|
Diseases in Twins | 1 | 1998 | 447 | 0.030 |
Why?
|
Treatment Failure | 2 | 2014 | 2664 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1866 | 0.030 |
Why?
|
Histone Code | 1 | 2016 | 160 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1327 | 0.030 |
Why?
|
Action Potentials | 1 | 2022 | 1838 | 0.030 |
Why?
|
Benzocaine | 1 | 2014 | 14 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 5044 | 0.030 |
Why?
|
Prenatal Diagnosis | 2 | 1994 | 1274 | 0.030 |
Why?
|
Australia | 1 | 2017 | 1265 | 0.030 |
Why?
|
Molecular Mimicry | 1 | 1995 | 213 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12775 | 0.030 |
Why?
|
Phenytoin | 1 | 2014 | 190 | 0.030 |
Why?
|
Binding Sites | 2 | 2014 | 6018 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4360 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 30230 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 1995 | 343 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5033 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2017 | 547 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2013 | 31 | 0.030 |
Why?
|
Down Syndrome | 2 | 1994 | 915 | 0.030 |
Why?
|
Cough | 1 | 2017 | 599 | 0.030 |
Why?
|
Nucleosomes | 1 | 2016 | 489 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 2013 | 79 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 590 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 2014 | 367 | 0.030 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 163 | 0.030 |
Why?
|
Phosphatidylinositols | 1 | 2013 | 280 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20224 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39405 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2819 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2014 | 331 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 370 | 0.020 |
Why?
|
Chorionic Gonadotropin | 1 | 1994 | 458 | 0.020 |
Why?
|
Radiotherapy | 2 | 2009 | 1509 | 0.020 |
Why?
|
Etoposide | 1 | 2013 | 639 | 0.020 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2013 | 221 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5443 | 0.020 |
Why?
|
RNA-Binding Protein EWS | 1 | 2013 | 211 | 0.020 |
Why?
|
Polysomnography | 1 | 2018 | 1865 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 937 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2014 | 284 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1155 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1216 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 2017 | 711 | 0.020 |
Why?
|
Genome, Human | 2 | 2016 | 4450 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 190 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 277 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3212 | 0.020 |
Why?
|
Protein Subunits | 1 | 2014 | 943 | 0.020 |
Why?
|
Fracture Fixation, Internal | 1 | 2017 | 980 | 0.020 |
Why?
|
Disease Progression | 3 | 2014 | 13646 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2016 | 914 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 1995 | 835 | 0.020 |
Why?
|
Autoantigens | 1 | 1995 | 891 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 691 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 419 | 0.020 |
Why?
|
Bacterial Translocation | 1 | 2009 | 74 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 612 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 551 | 0.020 |
Why?
|
Dyspnea | 1 | 2017 | 1351 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 725 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2012 | 2559 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4414 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2013 | 739 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 7595 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 904 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10776 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5916 | 0.020 |
Why?
|
COS Cells | 1 | 2010 | 1135 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2009 | 431 | 0.020 |
Why?
|
Diplopia | 1 | 2009 | 217 | 0.020 |
Why?
|
Program Development | 1 | 1994 | 1298 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1748 | 0.020 |
Why?
|
Human papillomavirus 18 | 1 | 2008 | 125 | 0.020 |
Why?
|
Oral Surgical Procedures | 1 | 2009 | 172 | 0.020 |
Why?
|
Cisplatin | 1 | 2013 | 1661 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2017 | 1421 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2569 | 0.020 |
Why?
|
Prospective Studies | 4 | 2016 | 54921 | 0.020 |
Why?
|
Human papillomavirus 16 | 1 | 2008 | 268 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5311 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 679 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3345 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 3728 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1958 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 594 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7145 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1905 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2010 | 1794 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2012 | 7885 | 0.010 |
Why?
|
Chromosomes, Human, 19-20 | 1 | 2003 | 11 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8730 | 0.010 |
Why?
|
Chromosomes, Human, 13-15 | 1 | 2003 | 49 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6993 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9371 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2429 | 0.010 |
Why?
|
Neurons | 1 | 2022 | 9512 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2636 | 0.010 |
Why?
|
Laryngoscopy | 1 | 2008 | 714 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10588 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3906 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1995 | 2257 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1995 | 2171 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 41791 | 0.010 |
Why?
|
DNA, Viral | 1 | 2008 | 2205 | 0.010 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2001 | 56 | 0.010 |
Why?
|
Epiglottis | 1 | 2001 | 81 | 0.010 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2001 | 56 | 0.010 |
Why?
|
DNA | 1 | 1995 | 7211 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6277 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6512 | 0.010 |
Why?
|
Pregnancy | 3 | 1998 | 30198 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2950 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6084 | 0.010 |
Why?
|
Genetic Variation | 1 | 2013 | 6606 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12801 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13499 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24316 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9508 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 21163 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2017 | 15854 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1995 | 340 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21544 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 16027 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1995 | 288 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 866 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1994 | 962 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 1755 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 1684 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1994 | 499 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1994 | 737 | 0.010 |
Why?
|
Maternal Age | 1 | 1994 | 809 | 0.010 |
Why?
|
United States | 1 | 2018 | 73144 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1988 | 862 | 0.000 |
Why?
|
Ultrasonography, Prenatal | 1 | 1994 | 1767 | 0.000 |
Why?
|
Gestational Age | 1 | 1994 | 3615 | 0.000 |
Why?
|
Genetic Testing | 1 | 1994 | 3587 | 0.000 |
Why?
|
Risk Factors | 1 | 1994 | 74954 | 0.000 |
Why?
|